These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 357279)

  • 41. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study.
    DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC
    J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prophylactic doxycycline for travelers' diarrhea. Results of a prospective double-blind study of Peace Corps volunteers in Kenya.
    Sack DA; Kaminsky DC; Sack RB; Itotia JN; Arthur RR; Kapikian AZ; Orskov F; Orskov I
    N Engl J Med; 1978 Apr; 298(14):758-63. PubMed ID: 342962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Travelers' diarrhea].
    Markwalder K
    Ther Umsch; 2001 Jun; 58(6):367-71. PubMed ID: 11441697
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recombinant DNA technology and enterotoxigenic Escherichia coli vaccines.
    Gyles CL; Maas WK
    Prog Vet Microbiol Immunol; 1987; 3():139-58. PubMed ID: 3078832
    [No Abstract]   [Full Text] [Related]  

  • 45. Etiology and epidemiology of travelers' diarrhea in Asia.
    Taylor DN; Echeverria P
    Rev Infect Dis; 1986; 8 Suppl 2():S136-41. PubMed ID: 3523709
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
    Svennerholm AM; Holmgren J
    Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
    [No Abstract]   [Full Text] [Related]  

  • 47. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans.
    Zhang W; Sack DA
    Expert Rev Vaccines; 2012 Jun; 11(6):677-94. PubMed ID: 22873126
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
    Gabutti G; Aquilina M; Cova M; Giuffrida S; Lizioli A; Protano D; Scrivano F; Tomasi A; Cucchi A; Cavallaro A;
    J Prev Med Hyg; 2012 Dec; 53(4):199-203. PubMed ID: 23469588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3)].
    Cravioto A
    Bol Med Hosp Infant Mex; 1984 May; 41(5):253-61. PubMed ID: 6147148
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of travelers' diarrhea: ciprofloxacin plus loperamide compared with ciprofloxacin alone. A placebo-controlled, randomized trial.
    Taylor DN; Sanchez JL; Candler W; Thornton S; McQueen C; Echeverria P
    Ann Intern Med; 1991 May; 114(9):731-4. PubMed ID: 2012354
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enterotoxigenic Escherichia coli and diffusely adherent E. coli as likely causes of a proportion of pathogen-negative travelers' diarrhea--a PCR-based study.
    Meraz IM; Jiang ZD; Ericsson CD; Bourgeois AL; Steffen R; Taylor DN; Hernandez N; DuPont HL
    J Travel Med; 2008; 15(6):412-8. PubMed ID: 19090795
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Environmental interventions for the prevention of travelers' diarrhea.
    Blaser MJ
    Rev Infect Dis; 1986; 8 Suppl 2():S142-50. PubMed ID: 3523710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot study of whole-blood gamma interferon response to the Vibrio cholerae toxin B subunit and resistance to enterotoxigenic Escherichia coli-associated diarrhea.
    Flores J; DuPont HL; Paredes-Paredes M; Aguirre-Garcia MM; Rojas A; Gonzalez A; Okhuysen PC
    Clin Vaccine Immunol; 2010 May; 17(5):879-81. PubMed ID: 20219880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. How to avoid running with Escherichia coli.
    Gorbach SL
    JAMA; 1980 Jan; 243(3):260-1. PubMed ID: 6985682
    [No Abstract]   [Full Text] [Related]  

  • 56. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA.
    Nandre RM; Ruan X; Duan Q; Sack DA; Zhang W
    Vaccine; 2016 Jun; 34(31):3620-5. PubMed ID: 27228947
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Travelers' knowledge of prevention and treatment of travelers' diarrhea.
    Johnson JY; McMullen LM; Hasselback P; Louie M; Saunders LD
    J Travel Med; 2006; 13(6):351-5. PubMed ID: 17107428
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccine development against enterotoxigenic Escherichia coli.
    Myers LL
    Prog Vet Microbiol Immunol; 1986; 2():145-57. PubMed ID: 3078647
    [No Abstract]   [Full Text] [Related]  

  • 59. Advice for travelers.
    Med Lett Drugs Ther; 1998 Apr; 40(1025):47-50. PubMed ID: 9590982
    [No Abstract]   [Full Text] [Related]  

  • 60. Escherichia coli originated from diarrhea of suckling piglets in Taiwan. V. Immunization for Escherichia coli diarrhea of suckling piglets.
    Chen C; Kume T; Hiruma M; Tsubaki S; Ando K; Sasahara J
    Kitasato Arch Exp Med; 1984 Dec; 57(4):253-65. PubMed ID: 6399724
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.